Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Flexion Therapeutics, Inc. (FLXN)

« Back to company index

FLXN Chatter Timeline

Stock Ticker for FLXN

Most Active Tweeters for FLXN

UserTweets
@Tickeron 13
@AmericanBanking 5
@OlympiaReport 5
@gcassidy718 5
@HealthcareBeat 5

Recent Tweets for FLXN

gcassidy718 @gcassidy718
$FLXN This one is getting bipolar : ) 4.06 % change recently https://t.co/N7BKQfHT0R
April 9th 2020, 2:04am
Tickeron @Tickeron
$FLXN in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on March 27, 2020. View odds for thi… https://t.co/UedGmlZNjy
April 8th 2020, 11:04pm
OlympiaReport @OlympiaReport
Flexion Therapeutics $FLXN Trading Up 16.5% https://t.co/V9cgCeF9qS
April 8th 2020, 6:04pm
stocknewstimes @stocknewstimes
-$0.98 Earnings Per Share Expected for Flexion Therapeutics Inc $FLXN This Quarter https://t.co/Q3un7sIzXE
April 8th 2020, 12:04pm
HealthcareBeat @HealthcareBeat
$20.60 Million in Sales Expected for Flexion Therapeutics Inc This Quarter $FLXN https://t.co/pxvVVmMQXN
April 8th 2020, 12:04pm
dailypoliticaln @dailypoliticaln
$20.60 Million in Sales Expected for Flexion Therapeutics Inc $FLXN This Quarter https://t.co/vdicJb5sFV
April 8th 2020, 12:04pm
dailypoliticaln @dailypoliticaln
Flexion Therapeutics Inc $FLXN Expected to Post Earnings of -$0.98 Per Share https://t.co/M9g6yyIWo2
April 8th 2020, 12:04pm
stocknewstimes @stocknewstimes
$20.60 Million in Sales Expected for Flexion Therapeutics Inc $FLXN This Quarter https://t.co/ATLuVaSjiC
April 8th 2020, 12:04pm
gcassidy718 @gcassidy718
$FLXN blockbuster 7.10 % change recently https://t.co/N7BKQfHT0R
April 8th 2020, 5:04am
Tickeron @Tickeron
$FLXN in Downtrend: 50-day Moving Average moved below 200-day Moving Average on March 27, 2020. View odds for this… https://t.co/neUhvuo2AV
April 7th 2020, 11:04pm
otcdynamics @otcdynamics
$FLXN Flexion Therapeutics to Present at the 19th Annual Needham Virtual Healthcare Conference https://t.co/UiVkFGKIN5
April 7th 2020, 4:04pm
HealthcareBeat @HealthcareBeat
Flexion Therapeutics to Present at the 19th Annual Needham Virtual Healthcare Conference $FLXN https://t.co/nCO0qqcKfM
April 7th 2020, 4:04pm
Tickeron @Tickeron
$FLXN in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on March 27, 2020. View odds for thi… https://t.co/g5wWk6i7Il
April 7th 2020, 12:04am
ChartMill @ChartMill
$FLXN has a Current Ratio of 5.40, so it is financially healthy and has no problem in meeting its obligations.… https://t.co/mzJiPjKrka
April 6th 2020, 5:04pm
dispatchtribune @dispatchtribune
Flexion Therapeutics $FLXN Stock Rating Upgraded by ValuEngine https://t.co/p96ccNuXla
April 6th 2020, 3:04pm
dailypoliticaln @dailypoliticaln
Flexion Therapeutics $FLXN Stock Rating Upgraded by ValuEngine https://t.co/9Xb5xlXRfm
April 6th 2020, 3:04pm
dailypoliticaln @dailypoliticaln
Flexion Therapeutics $FLXN Price Target Cut to $17.00 by Analysts at Benchmark https://t.co/3vg1SVfFb3
April 6th 2020, 3:04pm
TranscriptDaily @TranscriptDaily
Flexion Therapeutics $FLXN Stock Rating Upgraded by ValuEngine https://t.co/T44bUgl5Sc
April 6th 2020, 3:04pm
TranscriptDaily @TranscriptDaily
Flexion Therapeutics $FLXN Price Target Cut to $17.00 by Analysts at Benchmark https://t.co/6uBYyN3JiF
April 6th 2020, 3:04pm
ZolmaxNews @ZolmaxNews
-$0.91 EPS Expected for Flexion Therapeutics Inc $FLXN This Quarter https://t.co/VktQhtevv4
April 6th 2020, 6:04am
TheMarketsDaily @TheMarketsDaily
-$0.91 EPS Expected for Flexion Therapeutics Inc $FLXN This Quarter https://t.co/x1ul9Ky9SB
April 6th 2020, 6:04am
OlympiaReport @OlympiaReport
Flexion Therapeutics $FLXN Rating Increased to Buy at ValuEngine https://t.co/Mkmag9XHqw
April 6th 2020, 12:04am
OlympiaReport @OlympiaReport
Benchmark Trims Flexion Therapeutics $FLXN Target Price to $17.00 https://t.co/OjUFZipIjD
April 6th 2020, 12:04am
BlueBioNow @BlueBioNow
$FLXN this is the time you buy equities thank you fed -2.92 % change recently https://t.co/HjeJMAJFlT
April 5th 2020, 11:04pm
Tickeron @Tickeron
$FLXN in Downtrend: 50-day Moving Average moved below 200-day Moving Average on March 27, 2020. View odds for this… https://t.co/NmE39r0QqZ
April 5th 2020, 11:04pm
WatchlistN @WatchlistN
Flexion Therapeutics $FLXN Stock Rating Reaffirmed by Needham & Company LLC https://t.co/zSew29QYUG
April 5th 2020, 4:04am
ZolmaxNews @ZolmaxNews
Flexion Therapeutics $FLXN Stock Rating Reaffirmed by Needham & Company LLC https://t.co/aCyAhmnY6h
April 5th 2020, 4:04am
ThisLincolnian @ThisLincolnian
Flexion Therapeutics $FLXN Stock Rating Reaffirmed by Needham & Company LLC https://t.co/J5Ne1rBbw5
April 5th 2020, 4:04am
ThisLincolnian @ThisLincolnian
Analysts Anticipate Flexion Therapeutics Inc $FLXN Will Post Quarterly Sales of $23.73 Million https://t.co/JvzfjJbJSi
April 5th 2020, 4:04am
WatchlistN @WatchlistN
Analysts Anticipate Flexion Therapeutics Inc $FLXN Will Post Quarterly Sales of $23.73 Million https://t.co/EYUqqLjToH
April 5th 2020, 4:04am
AmericanBanking @AmericanBanking
Analysts Anticipate Flexion Therapeutics Inc $FLXN Will Post Quarterly Sales of $23.73 Million https://t.co/S5Gur5lUzN #stocks
April 5th 2020, 4:04am
EnterpriseLeade @EnterpriseLeade
Analysts Anticipate Flexion Therapeutics Inc $FLXN Will Post Quarterly Sales of $23.73 Million https://t.co/tLPLBFpfGW
April 5th 2020, 4:04am
TickerReport @TickerReport
Zacks: Brokerages Expect Flexion Therapeutics Inc $FLXN Will Announce Quarterly Sales of $23.73 Million https://t.co/D8lbdEZEwV
April 5th 2020, 4:04am
Tickeron @Tickeron
$FLXN in Downtrend: 50-day Moving Average moved below 200-day Moving Average on March 27, 2020. View odds for this… https://t.co/wnZByO4Kds
April 5th 2020, 12:04am
BlueBioNow @BlueBioNow
$FLXN good earnings are hopefully coming next quarter -2.92 % change recently https://t.co/HjeJMAJFlT
April 4th 2020, 10:04pm
ChartMill @ChartMill
$FLXN has a Current Ratio of 5.40, so it is financially healthy and has no problem in meeting its obligations.… https://t.co/1tZWEbH2eC
April 4th 2020, 9:04pm
OlympiaReport @OlympiaReport
Flexion Therapeutics $FLXN Given “Buy” Rating at Needham & Company LLC https://t.co/xZjV4XsUTJ
April 4th 2020, 5:04pm
InsiderAlertsIA @InsiderAlertsIA
$FLXN: New Insider Filing on Flexion Therapeutics Inc's Chief Commercial Officer MELISSA LAYMAN: https://t.co/mUuV0NZSZQ
April 4th 2020, 1:04pm
HealthcareBeat @HealthcareBeat
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635 $FLXN https://t.co/ej95Gw8BCZ
April 4th 2020, 5:04am
Tickeron @Tickeron
$FLXN in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on March 27, 2020. View odds for thi… https://t.co/zGqGPbNV4u
April 4th 2020, 12:04am
otcdynamics @otcdynamics
$FLXN Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://t.co/COJqN7iXTt
April 3rd 2020, 4:04pm
WeekHerald @WeekHerald
Brokerages Anticipate Flexion Therapeutics Inc $FLXN to Announce -$0.91 Earnings Per Share https://t.co/txMdDf2nVh
April 3rd 2020, 3:04pm
AmericanBanking @AmericanBanking
Brokerages Anticipate Flexion Therapeutics Inc $FLXN to Announce -$0.91 Earnings Per Share https://t.co/vHFGs6JbIf #stocks
April 3rd 2020, 3:04pm
Tickeron @Tickeron
$FLXN in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on March 27, 2020. View odds for thi… https://t.co/iUMSMAN1k6
April 3rd 2020, 12:04am
AmericanBanking @AmericanBanking
Flexion Therapeutics $FLXN Price Target Cut to $17.00 by Analysts at Benchmark https://t.co/GtJxKLIBWJ #stocks
April 2nd 2020, 9:04am
dispatchtribune @dispatchtribune
Flexion Therapeutics $FLXN PT Lowered to $17.00 at Benchmark https://t.co/G7oAyE69rB
April 2nd 2020, 9:04am
ConsumerFeed @ConsumerFeed
Flexion Therapeutics $FLXN Price Target Cut to $17.00 by Analysts at Benchmark https://t.co/TtG3rxzbf4
April 2nd 2020, 8:04am
HealthcareBeat @HealthcareBeat
Flexion Therapeutics Price Target Cut to $17.00 by Analysts at Benchmark $FLXN https://t.co/H3zmnAjZjf
April 2nd 2020, 8:04am
stocknewstimes @stocknewstimes
Flexion Therapeutics $FLXN Price Target Cut to $17.00 by Analysts at Benchmark https://t.co/0fA8ISPphM
April 2nd 2020, 8:04am
ZolmaxNews @ZolmaxNews
Flexion Therapeutics $FLXN Raised to Buy at ValuEngine https://t.co/VIUptpCneA
April 2nd 2020, 4:04am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.